News
Genetic Engineering & Biotechnology News highlighted Chicago and New Jersey as top biotech hubs in the U.S.
Read morePortal portfolio company, Moonlight Therapeutics launches its first-in-human Phase I clinical trial
Read morePortal portfolio company, Syntax Bio expands its Series A to $14.4 million
Read moreYou can build here.
Portal Innovations is a venture development platform that helps exceptional science-driven innovators build their companies where they live. We surround these entrepreneurs with the resources and community they need: Seed capital, fully equipped lab space, and expertise and introductions to other investors and partners.
Crafted capital™
Human
Financial
Physical
Portal Portfolio Company Acquired by Eli Lilly!
Eli Lilly acquires CrossBridge Bio, a Houston-based Portal portfolio company, in a deal up to $300M.
Portfolio + Partners
Founding sponsor
We are honored to have Walder Ventures as the founding sponsor of Portal Innovations. Our organizations share a bold vision to accelerate ambitious thinking in biomedical innovation and create a thriving ecosystem to support life science entrepreneurs. Read more.
Our partners
Get in touch
Chicago | Providence | New Brunswick | Houston | Dublin
©2026 Portal Innovations, LLC
Sign up for our monthly newsletter
Stay up-to-date on the latest VC, biotech, and med tech news in Chicago and across the U.S. Sign up with your email address below to get our monthly newsletter delivered to your inbox!